The 340B program requires drug manufacturers to provide outpatient drugs at a reduced price to certain covered entities.

The 340B program requires drug manufacturers to provide outpatient drugs at a reduced price to certain covered entities.

• A. Only inpatient drugs
• B. The 340B program requires drug manufacturers to provide outpatient drugs at a reduced price to certain covered entities
• C. Pediatric drugs only
• D. No price reduction

Answer: (B)

The fundamental idea being tested is that the 340B program provides discounted outpatient medications to eligible covered entities. This program is designed to help safety-net providers stretch limited resources by ensuring that outpatient drugs purchased by these entities are sold at reduced prices. Why this answer fits best: the discount applies specifically to outpatient drugs obtained by qualifying covered entities, not to inpatient medications. It’s not limited to pediatric drugs—discounts apply to outpatient drugs used across patient populations. And there is indeed a price reduction; saying there is no price reduction would be incorrect.

The fundamental idea being tested is that the 340B program provides discounted outpatient medications to eligible covered entities. This program is designed to help safety-net providers stretch limited resources by ensuring that outpatient drugs purchased by these entities are sold at reduced prices.

Why this answer fits best: the discount applies specifically to outpatient drugs obtained by qualifying covered entities, not to inpatient medications. It’s not limited to pediatric drugs—discounts apply to outpatient drugs used across patient populations. And there is indeed a price reduction; saying there is no price reduction would be incorrect.